p63 and p73 in Tumor Suppression and Promotion
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
The recent discovery of two genes, termed p63 and p73, encoding transcription factors highly homologous to p53 presents unexpected challenges and opportunities for the understanding and treatment of cancers. The questions raised are many but center on determining whether these new genes possess novel tumor suppressor functions, cooperate with p53, or impart oncogenic effects. At present there is considerable discord in the field concerning these concepts with some favoring a tumor suppressor role for the p53 family members and others an oncogenic influence. In support of a tumor suppressor role is the ability of p73 and p63 isoforms to transactivate p53 target genes and the large body of work linking p73, and to some extent p63, in apoptotic events in response to cellular stresses generally considered the purview of p53. More recently, p73 has been implicated in cell death following T cell activation, the response of cancers to chemotherapy, and finally, along with p63, to the function of p53 itself. Opposing this view is the fact that the p73 and p63 genes are rarely mutated in cancers and the stark absence of tumors in the p73 null mouse. Moreover, the high expression of dominant negative (dn) versions of the p73 and p63 proteins supports an anti-p53 function and therefore possibly an oncogenic effect. Indeed, the p63 gene is located in a region of chromosome three amplified in squamous cell carcinomas and the number of reports of dn-p63 overexpression in these diseases is increasing. This review will examine both sides of these arguments in an attempt to decipher common themes and to identify opportunities these genes represent for understanding tumorigenesis. (Cancer Res Treat. 2004;36:6-12)
참고문헌 (36)
- "Interaction of c-Abland p73alpha and their collaboration to induce apoptosis.", 399, pp.809~813 (1999)
- "Cloning and chromosomal mapping of thehuman p53-related KET gene to chromosome 3q27 and itsmurine homolog Ket to mouse chromosome 16.", 9, pp.899~902 (1998)
- "P53 polymorphisminfluences response in cancer chemotherapy via modulationof p73-dependent apoptosis.", 3, pp.387~402 (2003)
- "Drosophila p53 binds a damage responseelement at the reaper locus.", 101, pp.103~113 (2000)
- "P73 function is inhibitedby tumor-derived p53 mutants in mammalian cells.", 19, pp.1438~1449 (1999)
- "Bradley A. Mice deficient for p53are developmentally normal but susceptible to spontaneoustumours. Nature 1992", pp.215~221
- "P63 and p73 are required for p53-dependentapoptosis in response to DNA damage.", 416, pp.560~564 (2002)
- "The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.", 34, pp.850~856 (2003)
- "Cells, Embryos, and Evolution", Blackwell Science
- "The tyrosine kinase c-Abl regulates p73 inapoptotic response to cisplatin-induced DNA damage.", 399, pp.806~809 (1999)
- "Gain of chromosome 3q defines thetransition from severe dysplasia to invasive carcinoma of theuterine cervix.", 93, pp.479~484 (1996)
- "AIS is an oncogeneamplified in squamous cell carcinoma.", 97, pp.5462~5467 (2000)
- "Role for the p53 homologue p73 in E2F-1-induced apoptosis.", 407, pp.645~648 (2000)
- "Chemosensitivity linked to p73 function.", 3, pp.403~410 (2003)
- "P73 is a simian p53-relatedprotein that can induce apoptosis.", 389, pp.191~194 (1997)
- "Monoallelically expressed gene relatedto p53 at 1p36 a region frequently deleted in neuroblastomaand other human cancers.", 90, pp.809~819 (1997)
- "P53, the cellular gatekeeper for growth and division.", 88, pp.323~331 (1997)
- "Acommon E2F-1^p73 pathway mediates cell death inducedby TCR activation.", 407, pp.642~645 (2000)
- "A common polymorphism acts as an intragenicmodifier of mutant p53 behaviour.", 25, pp.47~54 (2000)
- "Drosophila p53 is a structural and functionalhomolog of the tumor suppressor p53.", 101, pp.91~101 (2000)
- "Cloning and functional analysis of human p51, which structurally and functionally resembles p53.", 4, pp.839~843 (1998)
- "Differential regulation of E2F1 apoptotic targetgenes in response to DNA damage.", 5(l), pp.552~558 (2003)
- "E2F-1 induced apoptosis.", pp.173~182 (2001)
- "An anti-apoptotic role for the p53 family member, p73, during developmental neuron death.", 289, pp.304~306 (2000)
- "A simple specific pattern of chromosomal aberrationsat early stages of head and neck squamous cell carcinomas PIK3CA but not p63 gene as a likely target of 3q26-qtergains.", 61, pp.4122~4129 (2001)
- "A second p53-related protein, p73L, with high homology to p73.", 30, pp.603~607 (1998)
- "Role of the p53-homologue p73 inE2F1-induced apoptosis.", 26, pp.464~469 (2000)
- "A new human p53 homologue.", 4, pp.747~748 (1998)
- "DNA damage enables p73.", 399, pp.734~735 (1999)
- "1p36: every subband a suppressor?", 31, pp.538~541 (1995)
- "P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.", 2, pp.305~316 (1998)
- "p63is essential for regenerative proliferation in limb, craniofacial and epithelial development.", 398, pp.714~718 (1999)
- "On the shoulders of giants: p63, p73 and the rise of p53.", 18, pp.90~95 (2002)
- "P63 and P73: P53 mimics, menaces and more.", 1, pp.199~207 (2000)
- "P73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.", 404, pp.99~103 (2000)
- "P73 is regulated by tyrosine kinase c-Abl inthe apoptotic response to DNA damage.", 399, pp.814~817 (1999)